TRANSCRIPTION REGULATION BY SV40 SMALL T
SV40 SMALL T 的转录调控
基本信息
- 批准号:2093873
- 负责人:
- 金额:$ 20.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-07-01 至 1996-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The transcription factor, EIIF, controls some RNA polymerase II
-transcribed genes that are induced in growing cells, such as c-myc, the
EGF receptor, and dihydrofolate reductase. It was first identified as a
host cell-encoded factor that binds to the Adenovirus E2A promoter. EIIF
can be found in a complex that includes the retinoblastoma gene product
(Rb) and cyclin A. Rb and cyclin A binding appear to inhibit
EIIF-dependent transcription. Rb and cyclin A are released from EIIF in
response to cell cycle control signals, or upon binding of Rb or cyclin A
by tumor virus oncogenes such as SV40 large T antigen or Adenovirus EIA.
We have previously discovered that SV40 small t antigen trans-activates
the E2A promoter during transient transfection with plasmid DNA and that
this requires the EIIF sites. Small t does not bind Rb and cyclin A.
Therefore, activation of EIIF-dependent transcription is likely to
involve novel, undiscovered mechanisms.
The transcription factors, TFIIIB and TFIIIC, control a class of RNA
polymerase III-transcribed genes that include tRNA genes and the
Adenovirus VA-I promoter. These transcription factors also appear to be
activated in growing, transformed, or virus infected cells. Small t
trans-activates the VA-I promoter during transient transfection. We have
found by testing small t mutants that different structures on small t
appear to be required to activate the E2A and the VA-I promoters.
Therefore, there may be at least two cellular processes that are
stimulated by small t.
We propose to investigate the mechanisms by which these two classes of
genes are regulated. We will use SV40 small t as an agent to investigate
these processes. We will examine these factors by gel shift analysis
using extracts of cells that express small t compared to those that do
not. Where possible, we will attempt to correlate any changes detectable
by gel shift analysis with increased transcription in vitro. We will
continue to study small t mutants to identify the structures required for
transcription regulation. This information will be used to determine how
small t interacts with cellular proteins the mediate its effects off
transcription. We will also examine whether the one identified cellular
protein that binds to small t, the enzyme type 2A phosphatase (PP2A),
mediates trans-activation by small t. Since the EIIF and TFIIIC factors
appear to be regulated by phosphorylation, it is possible that small t
activates transcription by inhibiting the dephosphorylation of its target
transcription factors. These experiments will outline pathways of
eukaryotic transcriptional control that may result in neoplastic
transformation which have not been revealed by investigation of other
systems.
转录因子EIIF控制一些RNA聚合酶II
- 在生长细胞中诱导的转录基因,如c-myc,
EGF受体和二氢叶酸还原酶。 它最初被确定为一种
结合腺病毒E2A启动子的宿主细胞编码因子。 EIIF
可以在一个包含视网膜母细胞瘤基因产物
(Rb)和细胞周期蛋白A。Rb和细胞周期蛋白A的结合似乎抑制了
EIIF依赖性转录。 Rb和细胞周期蛋白A从EIIF中释放,
对细胞周期控制信号的反应,或在Rb或细胞周期蛋白A结合后
通过肿瘤病毒癌基因如SV40大T抗原或腺病毒EIA。
我们以前发现SV40小t抗原反式激活
E2A启动子在用质粒DNA瞬时转染期间,
这需要EIIF网站。 小t不结合Rb和细胞周期蛋白A。
因此,EIIF依赖性转录的激活很可能
涉及新的未被发现的机制。
转录因子TFIIIB和TFIIIC控制一类RNA,
聚合酶III转录的基因,包括tRNA基因和
腺病毒VA-I启动子。 这些转录因子似乎也是
在生长、转化或病毒感染的细胞中活化。 小t
在瞬时转染期间反式激活VA-1启动子。 我们有
通过测试小t突变体发现,小t上的不同结构
似乎是激活E2A和VA-I启动子所必需的。
因此,可能存在至少两个细胞过程,
小T的刺激
我们建议调查这两类的机制,
基因受到调控。 我们将使用SV40小t作为代理进行调查
这些过程。 我们将通过凝胶位移分析来检验这些因素
使用表达小t的细胞提取物与表达小t的细胞提取物相比,
没有 在可能的情况下,我们会尝试将任何可检测到的变化
通过凝胶位移分析,体外转录增加。 我们将
继续研究小t突变体,以确定所需的结构,
转录调控 这些信息将用于确定如何
小t与细胞蛋白质相互作用,介导其效应,
转录。 我们还将检查是否有一个确定的细胞
与小t结合的蛋白质,2A型磷酸酶(PP2A),
通过小T介导反式激活。由于EIIF和TFIIIC因素
似乎是由磷酸化调节,这是可能的,小T
通过抑制其靶点的去磷酸化来激活转录
转录因子 这些实验将勾勒出
真核转录控制,可能导致肿瘤
其他研究尚未揭示的转变
系统.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARY R LOEKEN其他文献
MARY R LOEKEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARY R LOEKEN', 18)}}的其他基金
Role of Slc2a2/Glut2 in Embryo and Stem Cell Metabolism, Self-Renewal, and Pathways Involved in Diabetic Embryopathy
Slc2a2/Glut2 在胚胎和干细胞代谢、自我更新以及糖尿病胚胎病相关途径中的作用
- 批准号:
8913593 - 财政年份:2015
- 资助金额:
$ 20.56万 - 项目类别:
Embryonic Gene Expression During Diabetic Embryopathy
糖尿病胚胎病期间的胚胎基因表达
- 批准号:
8004610 - 财政年份:2009
- 资助金额:
$ 20.56万 - 项目类别:
EFFECT OF HYPERGLYCEMIA ON NEURALATING MOUSE EMBRYOS
高血糖对神经小鼠胚胎的影响
- 批准号:
7953823 - 财政年份:2008
- 资助金额:
$ 20.56万 - 项目类别:
EFFECT OF HYPERGLYCEMIA ON NEURALATING MOUSE EMBRYOS
高血糖对神经小鼠胚胎的影响
- 批准号:
6979993 - 财政年份:2003
- 资助金额:
$ 20.56万 - 项目类别:
MOLECULAR REGULATION: EMBYROGENESIS BY METABOLIC STRESS
分子调控:代谢应激的胚胎发生
- 批准号:
6643452 - 财政年份:2000
- 资助金额:
$ 20.56万 - 项目类别:
MOLECULAR REGULATION: EMBYROGENESIS BY METABOLIC STRESS
分子调控:代谢应激的胚胎发生
- 批准号:
6190733 - 财政年份:2000
- 资助金额:
$ 20.56万 - 项目类别:
MOLECULAR REGULATION: EMBYROGENESIS BY METABOLIC STRESS
分子调控:代谢应激的胚胎发生
- 批准号:
6524305 - 财政年份:2000
- 资助金额:
$ 20.56万 - 项目类别:
MOLECULAR REGULATION: EMBYROGENESIS BY METABOLIC STRESS
分子调控:代谢应激的胚胎发生
- 批准号:
6381856 - 财政年份:2000
- 资助金额:
$ 20.56万 - 项目类别:
Embryonic Gene Expression During Diabetic Embryopathy
糖尿病胚胎病期间的胚胎基因表达
- 批准号:
8442927 - 财政年份:2000
- 资助金额:
$ 20.56万 - 项目类别:
Embryonic Gene Expression During Diabetic Embryopathy
糖尿病胚胎病期间的胚胎基因表达
- 批准号:
7578310 - 财政年份:2000
- 资助金额:
$ 20.56万 - 项目类别:
相似海外基金
CAREER: Alternating Current Electrophoresis in Spatially Non-Uniform Electric Fields
职业:空间不均匀电场中的交流电泳
- 批准号:
2340925 - 财政年份:2024
- 资助金额:
$ 20.56万 - 项目类别:
Continuing Grant
High-resolution mass spectrometer with Liquid Chromatography (LC) and Capillary Electrophoresis (CE)
具有液相色谱 (LC) 和毛细管电泳 (CE) 功能的高分辨率质谱仪
- 批准号:
515835726 - 财政年份:2023
- 资助金额:
$ 20.56万 - 项目类别:
Major Research Instrumentation
Automated Electrophoresis Platform to Streamline Validations of Biomedical Samples
自动化电泳平台可简化生物医学样品的验证
- 批准号:
10710812 - 财政年份:2023
- 资助金额:
$ 20.56万 - 项目类别:
Microchip electrophoresis as basis for fully integrated, fully automated, low-cost radiopharmaceutical QC platform
微芯片电泳作为完全集成、全自动、低成本放射性药物 QC 平台的基础
- 批准号:
10697506 - 财政年份:2023
- 资助金额:
$ 20.56万 - 项目类别:
Sodium Dodecyl Sulfate Removal Interface to Enable Characterization of Fragment Impurities in Monoclonal Antibodies by Capillary Electrophoresis Sodium Dodecyl Sulfate Coupled to Mass Spectrometry
十二烷基硫酸钠去除接口可通过十二烷基硫酸钠毛细管电泳与质谱联用对单克隆抗体中的片段杂质进行表征
- 批准号:
10759354 - 财政年份:2023
- 资助金额:
$ 20.56万 - 项目类别:
New Advances in Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry for Accelerating Biomarker Discovery in Metabolomics
多段注射-毛细管电泳-质谱法加速代谢组学生物标志物发现的新进展
- 批准号:
RGPIN-2020-06630 - 财政年份:2022
- 资助金额:
$ 20.56万 - 项目类别:
Discovery Grants Program - Individual
Collaborative Research: Fundamental Mechanisms of Microfluidic Traveling-Wave Electrophoresis
合作研究:微流控行波电泳的基本机制
- 批准号:
2216766 - 财政年份:2022
- 资助金额:
$ 20.56万 - 项目类别:
Continuing Grant
Development of Desorption Techniques for Capillary Electrophoresis Analysis of Environmentally Toxic and Biochemically Active Contaminants on Nanoparticles and Nanomaterials in Water after Preconcentration by Liposome Encapsulation
脂质体封装预浓缩后水中纳米颗粒和纳米材料上环境毒性和生化活性污染物毛细管电泳分析解吸技术的发展
- 批准号:
RGPIN-2018-05320 - 财政年份:2022
- 资助金额:
$ 20.56万 - 项目类别:
Discovery Grants Program - Individual
Online Affinity Micro Free Flow Electrophoresis Assays for Continuous Monitoring of Biochemical Messengers
用于连续监测生化信使的在线亲和微自由流电泳分析
- 批准号:
10420769 - 财政年份:2022
- 资助金额:
$ 20.56万 - 项目类别: